Quarterly report pursuant to Section 13 or 15(d)

Patents

v3.7.0.1
Patents
9 Months Ended
May 31, 2017
Patents [Text Block]
9.

Patents


      May 31     August 31  
      2017     2016  
      $     $  
               
  Balance – Beginning   53,997     36,989  
  Addition   9,699     17,008  
  Amortization   (652 )   -  
  Balance – Ending   63,044     53,997  

The Company has filed multiple U.S. provisional patent applications, a U.S. utility patent application with continuation applications thereto and International patent applications under the Patent Cooperation Treaty (“PCT”) procedure. Filing under the PCT allows the Company to elect to pursue patent protection in up to 148 nations around the world. The patents provide an intellectual property protection for a number of molecules. The list of molecules infused within a unique lipid-formulation technology include THC, CBC, Nicotine, Non-Steroidal Anti- Inflammatories, certain Vitamins, edible starches (e.g. tapioca starch), and gum Arabic.

The Company was granted its first patent with a publish date of October 27, 2016. The patent is being amortized over its legal life of 20 years.